These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11444236)

  • 21. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
    El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
    J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Predication analysis of microarray data to determine altered gene profiles in liver carcinoma related to HBV-related cirrhosis].
    Liu J; Zhang Q; Li Z; Zhang Q; Qu Y; Lu L; Xu M
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):625-30. PubMed ID: 25243966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
    Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
    Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Gc system in liver cirrhosis and hepatoma.
    Theodoropoulos G; Rigatos G; Babionitakis A; Archimandritis A; Fertakis A; Melissinos K
    Hum Genet; 1977 Nov; 39(2):225-8. PubMed ID: 202558
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular pathogenesis of human hepatocellular carcinoma.
    Thorgeirsson SS; Grisham JW
    Nat Genet; 2002 Aug; 31(4):339-46. PubMed ID: 12149612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of ornithine decarboxylase messenger RNA in human hepatocellular carcinoma by in situ hybridization.
    Gan FY; Gesell MS; Moshier JA; Alousi M; Luk GD
    Epithelial Cell Biol; 1992 Jan; 1(1):13-7. PubMed ID: 1339180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
    Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Independent and additive interaction between polymorphisms of tumor necrosis factor α-308 and lymphotoxin α+252 on risk of hepatocellular carcinoma related to hepatitis B.
    Tsai JF; Chen SC; Lin ZY; Dai CY; Huang JF; Yu ML; Chuang WL
    Kaohsiung J Med Sci; 2017 Sep; 33(9):453-457. PubMed ID: 28865603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Methylation and other new concepts for the origin of hepatocellular carcinoma].
    Tannapfel A
    Pathologe; 2006 Jul; 27(4):284-8. PubMed ID: 16736175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of serum expression of GROβ in hepatocellular carcinoma.
    Li Y; Wang Y; Zhang P
    Tumour Biol; 2015 Aug; 36(8):6445-9. PubMed ID: 25801245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.
    Lechel A; Manns MP; Rudolph KL
    J Hepatol; 2004 Sep; 41(3):491-7. PubMed ID: 15336455
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial carcinoma and cirrhosis of liver: report of six members in two generations.
    Tansurat P
    J Med Assoc Thai; 1984 Sep; 67(9):529-34. PubMed ID: 6097626
    [No Abstract]   [Full Text] [Related]  

  • 33. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrahepatic recurrence of hepatocellular carcinoma 13 years after orthotopic liver transplantation for hepatitis C-related cirrhosis with occult hepatocellular carcinoma: a case report.
    Nelson AC; Jessurun J; Peterson RK; Pambuccian SE
    Liver Transpl; 2012 May; 18(5):612-4. PubMed ID: 22344889
    [No Abstract]   [Full Text] [Related]  

  • 35. Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
    Joung JG; Ha SY; Bae JS; Nam JY; Gwak GY; Lee HO; Son DS; Park CK; Park WY
    Oncotarget; 2017 Jan; 8(2):2076-2082. PubMed ID: 27409339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.
    van Dekken H; Wink J; Alers JC; de Man RA; IJzermans JN; Zondervan PE
    Acta Histochem; 2003; 105(1):29-41. PubMed ID: 12666986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study.
    Yeh MM; Liu Y; Torbenson M
    Hum Pathol; 2015 Nov; 46(11):1769-75. PubMed ID: 26410018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIVKA-II as a Potential New Biomarker for Hepatocellular Carcinoma - A Pilot Study.
    Svobodova S; Karlikova M; Topolcan O; Pecen L; Pestova M; Kott O; Treska V; Slouka D; Kucera R
    In Vivo; 2018; 32(6):1551-1554. PubMed ID: 30348715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TERT promoter mutations: gatekeeper and driver of hepatocellular carcinoma.
    Pinyol R; Tovar V; Llovet JM
    J Hepatol; 2014 Sep; 61(3):685-7. PubMed ID: 24859456
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevalence of the haemochromatosis gene mutation in non-cirrhotic liver with hepatocellular carcinoma.
    Bralet MP; Degott C; Belghiti J; Terris B
    J Hepatol; 1998 Apr; 28(4):740. PubMed ID: 9566848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.